common.study.topics.clinical

Drug on Urinary Sodium Excretion Response to Mental Stress

common.study.values.description

Effects of an Immunosuppressant Mycophenolate Mofetil or MMF on the Urinary Sodium Excretion Response to Mental Stress

The purpose of this study is to determine if stopping the stress induced increase in inflammation will prevent sodium retention which in turn increases blood pressure. Each subject will test two separate times. One week, they will be taking a daily dose of mycophenolate mofetil (MMF), the other week they will be taking a placebo.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - mycophenolate mofetil (MMF)

an immunosuppressant - 500 mgs twice a day for 7 1/2 days - in capsule form

Drug - Placebo

a sugar pill - 500 mgs twice a day for 7 1/2 days - in the same capsule form as the MMF

participant.views.study.view.additional

participant.views.study.view.scientific-title

Comparing the Effects of an Immunosuppressant (Mycophenolate Mofetil or MMF) on the Urinary Sodium Excretion Response to Mental Stress in a Crossover Design (MMF)

common.study.values.clinical-trial-id

NCT02432339

participant.views.study.view.id

BeXY8a